Sinco Pharmaceuticals Sets Out Board and Committee Structure

Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ) has shared an update.

Sinco Pharmaceuticals Holdings Limited has announced the current composition of its board, detailing the roles of one vice chairman, another executive director, a non-executive director, and four independent non-executive directors. The disclosure clarifies responsibility for oversight functions, with specific appointments to the audit, remuneration, nomination, and internal control and corporate governance committees.

The update underscores the company’s emphasis on governance by identifying committee chairpersons and members, particularly highlighting independent directors in key oversight roles. This structure is likely intended to strengthen transparency, risk management, and regulatory compliance, which are important considerations for shareholders and other market stakeholders.

More about Sinco Pharmaceuticals Holdings Ltd.

Sinco Pharmaceuticals Holdings Limited is a Cayman Islands–incorporated company listed in Hong Kong under stock code 6833. The firm operates in the pharmaceuticals sector, with a corporate governance structure that includes a board of executive, non-executive, and independent non-executive directors overseeing its strategic and compliance responsibilities.

Average Trading Volume: 213,363

Technical Sentiment Signal: Sell

Current Market Cap: HK$384.2M

Learn more about 6833 stock on TipRanks’ Stock Analysis page.